Influence
January 10, 2025

Asthma Among Children With Primary Ciliary Dyskinesia

Arthur H. Owora, PhD

Published in the journal JAMA Network Open. Here is a link to the article.

Regenstrief Institute authors: Arthur H. Owora, PhD, MPH

This case-control study investigated whether asthma should be routinely considered a comorbidity in children with primary ciliary dyskinesia (PCD), a condition caused by mutations in genes affecting motile cilia. Researchers analyzed data from two large electronic health record databases—Indiana Network for Patient Care Research (INPCR) and TriNetX—focusing on children 18 years or younger with both bronchiectasis and situs inversus totalis (B-SIT), a combination highly indicative of PCD. In INPCR, all 9 children with B-SIT had asthma, compared to 1 of 27 controls (P < .001). In TriNetX, 84 of 115 children with B-SIT had asthma, compared to 12 of 115 controls (P = 2.2 × 10⁻¹⁶), with an adjusted odds ratio of 22.3. The study concludes that asthma is significantly more common in children with likely PCD. This supports prior research suggesting antigen stasis in PCD may contribute to asthma-like inflammation. The findings suggest children with PCD should be evaluated for asthma, and some children with asthma may warrant evaluation for underlying PCD features.

Author Affiliations

Joe Zein 1Arthur Owora 2 3Hyun Jo Kim 4Nadzeya Marozkina 2Benjamin Gaston 2
Affiliations

Affiliations

1Department of Medicine, Division of Pulmonary and Sleep Medicine, Mayo Clinic, Scottsdale, Arizona.

2Department of Pediatrics and Riley Hospital for Children, Indiana University School of Medicine, Indianapolis.

3Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana.

4Department of Bioinformatics and Systems Biology, Case Western Reserve University, Cleveland, Ohio.

Related News

(From left to right) Dr. Brian Dixon, Dr. Sanji De Sylva and Isaac Vetter. Photo credit: Svetlana Efimova

Regenstrief experts advance global dialogue on digital health and interoperability at forum in Dubai

Regenstrief informaticians joined global leaders who shared their expertise at the 8th ZIMAM Digital Health Forum November 5-6, in

Regenstrief researchers join national stage to advance aging and gerontology research

Regenstrief Institute research scientists joined leading experts from across the nation at the Gerontological Society of America (GSA) 2025

illustration of the combination of interventions used in the D3 pragmatic clinical trial

Zero-cost, AI-driven digital detection identifies Alzheimer’s and related dementias without additional clinician time

Few primary care practices are designed for the timely detection of Alzheimer’s disease and related dementias. The limited time